Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tessa John

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Quality in Primary Care|May 29, 2014
Immunisation errors reported to a vaccine advice service: intelligence to improve practiceSarah Lang, Karen J Ford, Tessa John, et al.
Vaccine|April 29, 2014
Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccineDaniel O'Connor, Catrin E Moore, Matthew D Snape, et al.
Vaccine|July 2, 2016
The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK childrenMerryn Voysey, Rama Kandasamy, Ly-Mee Yu, et al.
The Pediatric Infectious Disease Journal|March 30, 2013
Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United KingdomGeraldine Blanchard-Rohner, Matthew D Snape, Dominic F Kelly, et al.
The Pediatric Infectious Disease Journal|September 17, 2010
Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trialAmeneh Khatami, Matthew D Snape, Tessa John, et al.
Vaccine|April 10, 2013
The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of ageGeraldine Blanchard-Rohner, Matthew D Snape, Dominic F Kelly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responseGeraldine Blanchard Rohner, Matthew D Snape, Dominic F Kelly, et al.
Vaccine|September 19, 2009
Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adultsIsabel Leroux-Roels, Marie Van der Wielen, Froukje Kafeja, et al.
Vaccine|March 8, 2012
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulationsAmeneh Khatami, Matthew D Snape, Elizabeth Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2014
An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solutionClaire S Waddington, Thomas C Darton, Claire Jones, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Quality in Primary Care|May 29, 2014
Immunisation errors reported to a vaccine advice service: intelligence to improve practiceSarah Lang, Karen J Ford, Tessa John, et al.
Vaccine|April 29, 2014
Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccineDaniel O'Connor, Catrin E Moore, Matthew D Snape, et al.
Vaccine|July 2, 2016
The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK childrenMerryn Voysey, Rama Kandasamy, Ly-Mee Yu, et al.
The Pediatric Infectious Disease Journal|March 30, 2013
Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United KingdomGeraldine Blanchard-Rohner, Matthew D Snape, Dominic F Kelly, et al.
The Pediatric Infectious Disease Journal|September 17, 2010
Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trialAmeneh Khatami, Matthew D Snape, Tessa John, et al.
Vaccine|April 10, 2013
The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of ageGeraldine Blanchard-Rohner, Matthew D Snape, Dominic F Kelly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responseGeraldine Blanchard Rohner, Matthew D Snape, Dominic F Kelly, et al.
Vaccine|September 19, 2009
Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adultsIsabel Leroux-Roels, Marie Van der Wielen, Froukje Kafeja, et al.
Vaccine|March 8, 2012
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulationsAmeneh Khatami, Matthew D Snape, Elizabeth Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 13, 2014
An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solutionClaire S Waddington, Thomas C Darton, Claire Jones, et al.
Pageof 2